Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cadence Pharmaceuticals Inc CADX

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:CADX)

Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc.

Business Wire March 19, 2014

Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results

PR Newswire February 28, 2014

Lifshitz & Miller Law Firm Announces Investigation of Cadence Pharmaceuticals, Inc., Chindex International, Inc., LCA-Vision, Inc., North Valley Bancorp and Texas Industries, Inc.

PR Newswire February 19, 2014

SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. in Connection With the Sale of the Company to Mallinckrodt plc

Business Wire February 17, 2014

CADENCE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

PR Newswire February 14, 2014

SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc.

Business Wire February 14, 2014

INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. and Its Board of Directors in Connection with the Sale of the Company to Mallinckrodt plc -- CADX

Business Wire February 13, 2014

CADENCE INVESTOR ALERT: Faruqi & Faruqi, LLP is Investigating Cadence Pharmaceuticals, Inc. (CADX) in Relation to the Proposed Sale of the Company to Mallinckrodt plc

Business Wire February 13, 2014

SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. - CADX

PR Newswire February 12, 2014

Opinion & Analysis (NDAQ:CADX)

No current opinion is available.

Bullboard Posts (NDAQ:CADX)